SGMT

SAGIMET BIOSCIENCES INC

SGMT·786700104·US·Common Stock·Healthcare - Biotechnology-13D/G

SGMT (SAGIMET BIOSCIENCES INC) is held by 58 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($5.7M), Woodline Partners LP ($5.2M), MARSHALL WACE, LLP ($5M). Net institutional sentiment: Mixed.

58
Holders
(6 Elite)
$56.9M
Total Value
67% (54)
Consensus
36 buying - 18 selling
13F: Insider & Congress:
SGMT

Smart Money Verdict

View all
Held by 58 funds
6 elite

Who's Trading

ActivistKPKPCB Pandemic and Bio Defense Fund, LLC0.0%Dec 18, 2025
InsiderKGKemble GeorgeSell $290KNov 20, 2025
ActivistWoodline Partners LPWoodline Partners LP4.8%Nov 14, 2025
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.0%Aug 14, 2025
InsiderHDHappel DavidSell $598KJul 21, 2025
InsiderRERozek ElizabethSell $98KJul 21, 2025
InsiderMBMartins Eduardo BrunoSell $76KJul 21, 2025
ActivistAPAP11 Limited4.9%Jun 24, 2025
ActivistNENew Enterprise Associates 13, L.P.0.0%May 13, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.1M$5.7M0.0%+31.14%
37
Unchanged
1M$5.2M0.0%-6.35%
0
Increased
966,253(+23.8%)$5M0.0%+26.94%
33
Unchanged
952,996$5M0.0%+0.79%
0
Increased
862,303(+46.9%)$4.5M0.0%+15.64%
37
Decreased
799,943(-1.7%)$4.2M0.0%+37.76%
0
Unchanged
724,800$3.8M0.2%-16.25%
0
Increased
625,469(+82.6%)$3.3M0.0%+21.44%
41
Decreased
411,570(-15.2%)$2.2M0.0%+3.59%
0
Increased
317,550(+10.9%)$1.7M0.0%+80.22%
28
Increased
309,522(+4.6%)$1.6M0.0%+41.39%
27
Decreased
303,223(-0.4%)$1.6M0.0%+25.98%
0
Increased
293,934(+45.7%)$1.5M0.0%+44.69%
35
Increased
271,217(+99.4%)$1.4M0.0%+30.91%
41
Increased
187,564(+6.7%)$980,0220.0%+26.29%
27
Increased
182,738(+64.1%)$954,8060.0%+15.41%
36
Increased
169,259(+34.4%)$884,3790.0%+29.53%
32
New
162,618$849,6790.0%+31.14%
34
Increased
128,788(+9.7%)$672,9170.0%+41.34%
18
Decreased
124,604(-30.4%)$651,0560.0%+35.05%
0

Showing 1-20 of 62

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used